-
November 06, 2012
Onyx Pharmaceuticals Inc. (ONXX) reported a loss of 89 cents per share in the third quarter of 2012, narrower than ...
-
November 05, 2012
Encouraged by strong second quarter 2012 results, upbeat guidance and a series of positive subsequent developments, ...
-
October 31, 2012
Recently, the HealthCare unit of Bayer (BAYRY) announced that its oncology drug Stivarga (regorafenib) will be ...
-
October 30, 2012
Bayer's (BAYRY) earnings during the third quarter of 2012 came in at ¬1.20 per share (approx $1.50) compared with ...
-
October 29, 2012
Regeneron Pharmaceuticals Inc.'s (REGN) third quarter 2012 earnings (excluding special items but including ...
-
October 24, 2012
Sigma-Aldrich Corporation (SIAL) announced a collaboration between Sigma Advanced Genetic Engineering (SAGE) Labs - ...
-
October 23, 2012
Global lab chemical and life sciences company Sigma-Aldrich Corporation (SIAL) posted adjusted earnings (excluding ...
-
October 19, 2012
Watson Pharmaceuticals, Inc. (WPI) recently received a favorable vote from the Federal Trade Commission (FTC) for ...
-
October 17, 2012
Denmark-based Novo Nordisk (NVO) is seeking regulatory approval for its hemophilia A candidate turoctocog alfa ...
-
October 16, 2012
Sigma Life Science, the innovative biological products and services research wing of Sigma-Aldrich Corporation ...
-
October 05, 2012
Sigma Life Science, the innovative biological products and services research wing of Sigma-Aldrich Corporation ...
-
October 02, 2012
Sigma-Aldrich Corporation (SIAL) announced that it has received recognition from The Carbon Disclosure Project ...
-
September 28, 2012
The HealthCare unit of Bayer (BAYRY) recently announced that the US Food and Drug Administration (FDA) has cleared ...
-
September 27, 2012
The US approval process of Bristol-Myers Squibb Company/Pfizer Inc.'s (BMY/PFE) anti-clotting drug Eliquis ...
-
September 24, 2012
Recently, Bristol-Myers Squibb Company (BMY) and partner, Pfizer Inc. (PFE) received some encouraging news with the ...
-
September 24, 2012
Good news flowed in at Regeneron Pharmaceuticals, Inc. (REGN) from both the US and Europe regarding its eye drug ...
-
September 21, 2012
The HealthCare unit of Bayer (BAYRY) announced recently that it has filed an application seeking approval to market ...
-
September 21, 2012
Sanofi (SNY) recently announced that it has entered into a research collaboration agreement with the Global Alliance ...
-
September 21, 2012
Spectrum Pharmaceuticals, Inc. (SPPI) recently initiated the phase III ZEST (Zevalin Evaluation as Sequential ...
-
September 19, 2012
Encouraged by strong second quarter 2012 results, an upbeat guidance and a series of positive subsequent ...
